Perioperative management of the post-gastric-bypass patient presenting for body contour surgery

Clinics in Plastic Surgery

Volumn 31, Issue 4 SPEC. ISS., 2004, Pages 601-610

  Peter Rubin, J ^a   Nguyen, Vu ^a   Schwentker, Ann ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; THIAMINE;

ABDOMINAL WALL HERNIA; ARTICLE; BARIATRIC SURGERY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HEART DISEASE; HUMAN; LUNG DISEASE; NUTRITION; PERIOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTOR; SCREENING; SLEEP APNEA SYNDROME; SOCIAL PSYCHOLOGY; STOMACH BYPASS; THIAMINE DEFICIENCY; THROMBOCYTOPENIA; THROMBOEMBOLISM; WEIGHT REDUCTION; WOUND INFECTION;

EID: 4444292596     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2004.03.017     Document Type: Review

References (84)

1. NHLBI Obesity Education Initiative Expert Panel Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. 1998;National Institutes of Health, Bethesda, MD. (#NIH 98-40833.)
2. Dixon J.B., O'Brien P.E. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg. 184:2002;51S-54S
3. Dhabuwala A., Cannan R.J., Stubbs R.S. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg. 10:2000;428-435
4. Choban P.S., Onyejekwe J., Burge J.C., Flancbaum L. A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinical severe obesity. J Am Coll Surg. 188:1999;491-497
5. Vidal J. Updated review on the benefits of weight loss. Int J Obes. 26:2002;S25-S28
6. Deitel M. How much weight loss is sufficient to overcome major co-morbidities? Obes Surg. 11:2001;659
7. Kelly H.A. Excision of fat of the abdominal wall - lipectomy. Surg Gynec Obst. 10:1910;229
8. Gonzalez-Ulloa M. Belt lipectomy. Br J Plast Surg. 13:1961;179-186
9. Postlethwait R.W., Johnson W.D. Complications following surgery for duodenal ulcer in obese patients. Arch Surg. 105:1972;438-440
10. Pembertori L.B., Manax W.G. Relationship of obesity to postoperative complications after cholecystectomy. Am J Surg. 121:1971;87-90
11. Pitkin R.M. Abdominal hysterectomy in obese women. Surg Gynecol Obstet. 142:1976;532-536
12. Thomas E.J., Goldman L., Mangione C.M., et al. Body mass index as a correlate of postoperative complications and resource utilization. Am J Med. 102:1997;277-283
13. Latimer R.G., Dickman M., Day W.C., et al. Ventilatory patterns and pulmonary complications after upper abdominal surgery determined by preoperative and postoperative computerized spirometry and blood gas analysis. Am J Surg. 122:1971;622-632
14. Gould A.B. Effect of obesity on respiratory complications following general anesthesia. Anesth Analg. 41:1962;448-452
15. Colwell C.W., Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthropasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg. 81:1999;932-940
16. White R.H., Gettner S., Newman J.M., et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 343:2000;1758-1764
17. Prem K.A., Mensheha N.M., McKelvey J.L. Operative treatment of adenocarcinoma of the endometrium in obese women. Am J Obstet Gynecol. 92:1965;16-22
18. Matory W.E., O'Sullivan J., Fudem G., Dunn R. Abdominal surgery in patients with severe morbid obesity. Plast Reconstr Surg. 94:1994;976-987
19. Vastine V.L., Morgan R.F., Williams G.S. Wound complications of abdominoplasty in obese patients. Ann Plast Surg. 42:1999;34-39
20. Deitel M. How much weight loss is sufficient to overcome major co-morbidities? Obes Surg. 11:2001;659
21. Kuhlmann H.W., Falcone R.A., Wolf A.M. Cost-effective bariatric surgery in Germany today. Obes Surg. 10:2000;549-552
22. Pinkney J.H., Sjostrom C.D., Gale E.A. Should surgeons treat diabetes in severely obese people? Lancet. 357:2001;1357-1359
23. Goldstein D.J. Beneficial health effects of modest weight loss. Int J Obes. 16:1991;397-415
24. Thomas P.R. Weighing the options. Criteria for evaluating weight-management programs. 1995;Institute of Medicine, Washington, DC
25. Van Gaal L.F., Wauters M.A., De Leeuw I.H. The beneficial effect of modest weight loss on cardiovascular risk factors. Int J Obes. 21:1997;S5-S9
26. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 222:1995;339-350
27. Carson J.L., Ruddy M.E., Duff A.E., et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 154:1994;193-200
28. Benotti P.N., Bistrain B., Benotti J.R., et al. Heart disease and hypertension in severe obesity: the benefits of weight reduction. Am J Clin Nutr. 55:1992;586S-590S
29. Foley E.F., Benotti P.N., Borlase B.C., et al. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg. 163:1992;294-297
30. Gleysteen J.J., Barboriak J.J. Improvement in heart disease risk factors after gastric bypass. Arch Surg. 118:1983;681-684
31. Choban P.S., Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg. 185:1997;593-603
32. Zammit G.K. Sleep disorders associated with obesity. VanItallie T.B., Simopoulos A. Obesity, new directions in assessment and management. 1995;60-72 The Clark Press, Philadelphia
33. Charuzi I., Lavie P., Peiser J., Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr. 55:1992;594S-596S
34. Sugerman J.H., Baron P.L., Fairman R.P., et al. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg. 207:1988;604-613
35. Jenkins S.C., Moxham J. The effects of mild obesity on lung function. Resp Med. 85:1991;309-311
36. Ruhl C.E., Everhart J.E. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol. 9:1999;424-435
37. Barak N., Ehrenpreis E.D., Harrison J.R., Sitrin M.D. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev. 3:2002;9-15
38. Frezza E.E., Ikramuddin S., Gourash W., et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 16:2002;1027-1031
39. Smith S.C., Edwards C.B., Goodman G.N. Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg. 7:1997;479-484
40. Jones K.B., Allen T.V., Manas K.J., et al. Roux-en-Y gastric bypass: an effective antireflux procedure. Obes Surg. 1:1991;295-298
41. Colwell C.W., Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthropasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg. 81:1999;932-940
42. Coon W.W. Risk factors in pulmonary embolism. Surg Gynecol Obstet. 143:1976;385-390
43. Blaszyk H., Wollan P.C., Witkiewicz A.K., et al. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch Pathol Anat Physiol Klin Med. 434:1999;529-532
44. Blaszyk H., Bjornsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg. 135:2000;1410-1413
45. Aly A.S., Cram A.E., Chao M., et al. Belt lipectomy for circumferential truncal excess: the University of Iowa experience. Plast Reconstr Surg. 111:2003;398-413
46. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest. 119:2001;132S-175S
47. Imperiale T.F., Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA. 271:1994;1780-1785
48. Koch A., Bouges S., Ziegler S., et al. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg. 84:1997;750-759
49. Palmer A.J., Schramm W., Kirchhof B., Bergemann R. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomized clinical trials. Haemostasis. 27:1997;65-74
50. Warkentin T.E., Levine M.N., Hirsh J., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med. 332:1995;1330-1335
51. Kaboli P., Henderson M.C., White R.H. DVT prophylaxis and anticoagulation in the surgical patient. Med Clin N Am. 87:2003;77-110
52. Dean P., Joshi S., Kaminski D.L. Long-term outcome of reversal of small intestinal bypass operations. Am J Surg. 159(1):1990;118-123. discussion: 123-4
53. Halverson J.D., Gentry K., Wise L., Ballinger W.F. Reanastomosis after jejunoileal bypass. Surgery. 84(2):1978;241-249
54. Halverson J.D. Metabolic risk of obesity surgery and long-term follow-up. Am J Clin Nutr. 55(2 Suppl):1992;602S-605S
55. Quaranta L., Nascimbeni G., Semeraro F., Quaranta C.A. Severe corneoconjunctival xerosis after biliopancreatic bypass for obesity (Scopinaro's operation). Am J Ophthalmol. 118(6):1994;817-818
56. Kushner R. Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature. J Parenter Enteral Nutr. 24(2):2000;126-132
57. Sugerman H.J., Starkey J.V., Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg. 205(6):1987;604-613
58. Abarbanel J.M., Berginer V.M., Osimani A., et al. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology. 37(2):1987;196-200
59. Griffen W.O. Jr., Young V.L., Stevenson C.C. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 186(4):1977;500-509
60. Hermreck A.S., Jewell W.R., Hardin C.A. Gastric bypass for morbid obesity: results and complications. Surgery. 80(4):1976;498-505
61. Amaral J.F., Thompson W.R., Caldwell M.D., et al. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Ann Surg. 201(2):1985;186-193
62. Brown E.K., Settle E.A., Van Rij A.M. Food intake patterns of gastric bypass patients. J Am Diet Assoc. 80(5):1982;437-443
63. Feit H., Glasberg M., Ireton C., et al. Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med. 96(4):1982;453-455
64. Villar H.V., Ranne R.D. Neurologic deficit following gastric partitioning: possible role of thiamine. J Parenter Enteral Nutr. 8(5):1984;575-578
65. Tanphaichitr V. Thiamine. Shils M.E., Olson J.A., Shike M., Ross A.C. Modern nutrition in health and disease. 1999;381-389 Williams & Wilkins, Philadelphia
66. Avinoah E., Ovnat A., Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery. 111(2):1992;137-142
67. Van Way C.W. Nutritional support in the injured patient. Surg Clin North Am. 71:1991;537-548
68. James T.J., Hughes M.A., Cherry G.W., Taylor R.P. Simple biochemical markers to assess chronic wounds. Wound Repair & Regeneration. 8(4):2000;264-269
69. Vogt P.M., Lehnhardt M., Wagner D., et al. Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion. Plast Reconstr Surg. 102(1):1998;117-123
70. Ott M.T., Fanti P., Malluche H.H., Ryo U.Y., Whaley F.S., Strodel W.E., et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 2:1992;341-348
71. Charles P. Calcium absorption and calcium bioavailability. J Intern Med. 231(2):1992;161-168
72. Crowley L.V., Seay J., Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol. 79(11):1984;850-860
73. Halverson J.D. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg. 52(11):1986;594-598
74. Provenzale D., Reinhold R.B., Golner B., et al. Evidence for diminished B12 absorption after gastric bypass: oral supplementation does not prevent low plasma B12 levels in bypass patients. J Am Coll Nutr. 11(1):1992;29-35
75. Behrns K.E., Smith C.D., Sarr M.G. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci. 39(2):1994;315-320
76. Marcuard S.P., Sinar D.R., Swanson M.S., et al. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci. 34(8):1989;1238-1242
77. Rhode B.M., Arseneau P., Cooper B.A., et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr. 63(1):1996;103-109
78. Beard J.L., Dawson H., Pinero D.J. Iron metabolism: a comprehensive review. Nutr Rev. 54(10):1996;295-317
79. Lash A., Saleem A. Iron metabolism and its regulation. A review. Ann Clin Lab Sci. 25(1):1995;20-30
80. Brolin R.E., Gorman J.H., Gorman R.C., et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg. 133(7):1998;740-744
81. Herbert V., Das K.C. Folic acid and vitamin B12. Shils M.E., Olson J.A., Shike M. Modern nutrition in health and disease. 1994;402-425 Lea & Febiger, Philadelphia
82. Dixon J.B., Dixon M.E., O'Brien P.E. Pregnancy after Lap-Band surgery: management of the band to achieve healthy weight outcomes. Obes Surg. 11(1):2001;59-65
83. Martin L.F., Finigan K.M., Nolan T.E. Pregnancy after adjustable gastric banding. Obstet Gynecol. 95(6 Pt. 1):2000;927-930
84. Weiss H.G., Nehoda H., Labeck B., et al. Pregnancies after adjustable gastric banding. Obes Surg. 11(3):2001;303-306